Global Superdisintegrants Market

Global Superdisintegrants Market Size, Trends & Analysis - Forecasts to 2026 By Product type [Croscarmellose Sodium, Crospovidone, Sodium Starch Glycolate, Ion Exchange Resin, Others], By Dosage Forms [Tablets and Capsules, Mouth-dissolving Films], By Region (North America, Asia Pacific, CSA, Europe, and the Middle East and Africa); Company Market Share Analysis & Competitor Analysis

Category Healthcare

Format

This report was recently updated on April 12 2024 with the latest and most recent market numbers

Superdisintegrants Market Insights

Disintegrants are chemicals added to medicine formulations to aid in the breakdown of capsules and tablets into readily dissolvable particles. This is important for the rapid absorption of medications, which improves their potency. Superdisintegrants are disintegrants with a small modification that are more efficient than their standard equivalents.

Despite the increased interest in other drug delivery routes, the appeal of orally administered medications has not completely faded. There is still a sizable market for pharmaceuticals administered in the form of pills, tablets, and capsules, which is where Superdisintegrants are still in demand. While synthetic Superdisintegrants have dominated the market so far, GME predicts that the emergence of a novel class of natural Superdisintegrants will have a long-term influence on the industry's growth. In the medical business, the need for Superdisintegrants is directly related to the need for solid dosage forms.

Excellent compressibility, low solubility, a good mouthfeel, and compatibility with other active ingredients used in medication formulation are some of the most admirable characteristics of Superdisintegrants.

The pharmaceutical business is expanding at a dizzying pace, and it is quickly becoming an important aspect of the healthcare business. This is mostly attributable to an increase in the number of elderly and pediatric patients. Because these pills are simpler to swallow, Superdisintegrants are useful for treating individuals. The market is likely to develop as these demographics develop. Furthermore, generic medications are in huge demand since patents on some famous medicine names have begun to expire, opening the pharmaceutical sector to greater competition and a surge in generic drug manufacture, fuelling demand for superdisintegrants.

Expansion in the generic market, the emergence of new superdisintegrants for the pharmaceutical sector, rising geriatric population who have difficulty with swollen tablets or capsules, rising demands for Superdisintegrants products, growing R&D activities, increased R&D investment, and rising adoption rate of novel drug delivery systems are some of the factors driving the Superdisintegrants market during the forecast period.

global superdisintegrants market

Superdisintegrants Market: By Product

Based on the product, the superdisintegrants market can be segmented as croscarmellose sodium, crospovidone, sodium starch glycolate, and ion exchange resin, among others. Crospovidone has held the largest market share in the past. It will see a larger share in the market in the future. Crospovidone can stabilize pharmaceuticals in their amorphous form by inhibiting drug recrystallization and having fast permanent solutions. Crospovidone, which is commonly employed in the manufacturing of pills, granules, and capsules, also has a good disintegration and dissolving boosting effect. During the projection period, all of these variables will contribute to the Crospovidone segment's growth.

During the projection period, the others category, which comprises natural Superdisintegrants like Isapghula husk, gellan gum, and locust bean gum, is predicted to expand at the fastest growth rate. Because of its high hydrophilic nature, it instantly swells when it comes into touch with water, resulting in quick tablet disintegration. Apart from Superdisintegrants, scientists are always looking for new disintegrating substances. Modified natural goods including chitin, chitosan, polymerized agar acrylamide, xylem, cross-linked carboxymethyl guar, and modified tapioca starch have all been tested.

Superdisintegrants Market: By Dosage Forms

Based on the dosage forms, the superdisintegrants market is divided into tablets and capsules and mouth-dissolving films. The tablets and capsules segment is likely to have the largest share in the market in the predicted timeframe. The frequent deployment of ODTs and fast-disintegrating pills among healthcare professionals and patients leads to the large manufacturing of these goods by pharma companies, which accounts for the high proportion of this market. The significant demand for ODTs and FDTs may be attributed to their advantages, which include greater drug availability, improved pre-gastric absorption, ease of swallowing in dysphagia patients, ease of administration, and improved shelf life. Tablets and capsules have a speedy dissolving dosage form that is recognized by the FDA, and they are mentioned in authorized drug products with therapeutic equivalency studies, boosting the segment's expansion.

asia pacific superdisintegrants market

Superdisintegrants Market: By Region

As per the geographical analysis, the market can be classified into North America (the US, Canada, and Mexico), Asia Pacific (India, China, Japan, Malaysia, Singapore, and Rest of Asia Pacific), Europe (Germany, United Kingdom, Italy, France, Spain, Netherlands, and Rest of Europe), Middle East & Africa and Central & South America. In previous years, North America led the Superdisintegrants sector, accounting for the majority of sales. Growing demand for generic pharmaceuticals, improved innovation in the development of superdisintegrants, and manufacturing methodologies are only a few of the market's elevated key drivers. Furthermore, North America is home to some of the most important companies in the Superdisintegrants industry.

APAC region, on the other side, is predicted to increase at the quickest rate throughout the projection period. Growth in the APAC area is likely to be driven by factors such as increased outsourcing of active ingredients, including Superdisintegrants, production of new Superdisintegrants, and acceptance of new technology. The R&D activities are also increasing in the region and hence it can also make the market rise during the predicted timeframe. Moreover, Low-cost manufacturing, rising per capita income, and lax regulatory oversight are all contributing to the superdisintegrants market's expansion in these regions.

Superdisintegrants Market Share and Competitor Analysis

Ashland Global Holdings Inc., BASF SE, Merck KGaA, DuPont, Roquette Frères S.A., FMC Corporation, DFE Pharma, Huber Corporation, JRS Pharma, Avantor, Corel Pharma Chem, and Nippon Soda Co., Ltd., among others, are the top players in the superdisintegrants market.

Please note: This is not an exhaustive list of companies profiled in the report.

In October 2017, in Biopolis, Singapore, Roquette established its new Pharmaceutical R&D and Customer Technical Service for the production of new products and new applications for current products, as well as pre-clinical research.

Chapter 1 Methodology

1.1 Market Scope & Definitions

1.2 Estimates & Forecast Calculation

1.3 Historical Data Overview And Validation

1.4 Data Sources

1.4.1 Secondary

1.4.2 Primary

Chapter 2 Report Outlook

2.1 Global Superdisintegrants Industry Overview, 2016-2026

2.1.1 Industry Overview

2.1.2 Product Overview

2.1.3 Dosage Form Overview

2.1.4 Regional Overview

Chapter 3 Global Superdisintegrants Market Trends

3.1 Market Segmentation

3.2 Industry Background, 2016-2026

3.3 Market Key Trends

3.3.1 Positive Trends

3.3.1.1 Pharmaceutical market expansion in emerging countries

3.3.1.2 Growing adoption of orally disintegrating tablets

3.3.2 Industry Challenges

3.3.2.1 Safety and Quality Concerns

3.4 Prospective Growth Scenario

3.4.1 Product Growth Scenario

3.4.2 Dosage Form Growth Scenario

3.5 COVID-19 Influence over Industry Growth

3.6 Porter’s Analysis

3.7 PESTEL Analysis

3.8 Value Chain & Supply Chain Analysis

3.9 Regulatory Framework

3.9.1 North America

3.9.2 Europe

3.9.3 APAC

3.9.4 LATAM

3.9.5 MEA

3.10 Technology Overview

3.11 Market Share Analysis, 2020

3.11.1 Company Positioning Overview, 2020

Chapter 4 Global Superdisintegrants Market, By Product

4.1 Product Outlook

4.2 Crospovidone

4.2.1 Market Size, By Region, 2016-2026 (USD Million)

4.3 Croscarmellose sodium

4.3.1 Market Size, By Region, 2016-2026 (USD Million)

4.4 Sodium starch glycolate

4.4.1 Market Size, By Region, 2016-2026 (USD Million)

4.5 Ion exchange resin

4.5.1 Market Size, By Region, 2016-2026 (USD Million)

4.6 Others

4.6.1 Market Size, By Region, 2016-2026 (USD Million)

Chapter 5 Superdisintegrants Market, By Dosage Form

5.1 Dosage Form Outlook

5.2 Tablets and Capsules

5.2.1 Market Size, By Region, 2016-2026 (USD Million)

5.3 Mouth-dissolving Films

5.3.1 Market Size, By Region, 2016-2026 (USD Million)

Chapter 6 Superdisintegrants Market, By Region

6.1 Regional outlook

6.2 North America

6.2.1 Market Size, By Country 2016-2026 (USD Million)

6.2.2 Market Size, By Product, 2016-2026 (USD Million)

6.2.3 Market Size, By Dosage Form, 2016-2026 (USD Million)

6.2.4 U.S.

6.2.4.1 Market Size, By Product, 2016-2026 (USD Million)

6.2.4.2 Market Size, By Dosage Form, 2016-2026 (USD Million)

6.2.5 Canada

6.2.5.1 Market Size, By Product, 2016-2026 (USD Million)

6.2.5.2 Market Size, By Dosage Form, 2016-2026 (USD Million)

6.3 Europe

6.3.1 Market Size, By Country 2016-2026 (USD Million)

6.3.2 Market Size, By Product, 2016-2026 (USD Million)

6.3.3 Market Size, By Dosage Form, 2016-2026 (USD Million)

6.3.4 Germany

6.2.4.1 Market Size, By Product, 2016-2026 (USD Million)

6.2.4.2 Market Size, By Dosage Form, 2016-2026 (USD Million)

6.3.5 UK

6.3.5.1 Market Size, By Product, 2016-2026 (USD Million)

6.3.5.2 Market Size, By Dosage Form, 2016-2026 (USD Million)

6.3.6 France

6.3.6.1 Market Size, By Product, 2016-2026 (USD Million)

6.3.6.2 Market Size, By Dosage Form, 2016-2026 (USD Million)

6.3.7 Italy

6.3.7.1 Market Size, By Product, 2016-2026 (USD Million)

6.3.7.2 Market Size, By Dosage Form, 2016-2026 (USD Million)

6.3.8 Spain

6.3.8.1 Market Size, By Product, 2016-2026 (USD Million)

6.3.8.2 Market Size, By Dosage Form, 2016-2026 (USD Million)

6.3.9 Russia

6.3.9.1 Market Size, By Product, 2016-2026 (USD Million)

6.3.9.2 Market Size, By Dosage Form, 2016-2026 (USD Million)

6.4 Asia Pacific

6.4.1 Market Size, By Country 2016-2026 (USD Million)

6.4.2 Market Size, By Product, 2016-2026 (USD Million)

6.4.3 Market Size, By Dosage Form, 2016-2026 (USD Million)

6.4.4 China

6.4.4.1 Market Size, By Product, 2016-2026 (USD Million)

6.4.4.2 Market Size, By Dosage Form, 2016-2026 (USD Million)

6.4.5 India

6.4.5.1 Market Size, By Product, 2016-2026 (USD Million)

6.4.5.2 Market Size, By Dosage Form, 2016-2026 (USD Million)

6.4.6 Japan

6.4.6.1 Market Size, By Product, 2016-2026 (USD Million)

6.4.6.2 Market Size, By Dosage Form, 2016-2026 (USD Million)

6.4.7 Australia

6.4.7.1 Market Size, By Product, 2016-2026 (USD Million)

6.4.7.2 Market size, By Dosage Form, 2016-2026 (USD Million)

6.4.8 South Korea

6.4.8.1 Market Size, By Product, 2016-2026 (USD Million)

6.4.8.2 Market Size, By Dosage Form, 2016-2026 (USD Million)

6.5 Latin America

6.5.1 Market Size, By Country 2016-2026 (USD Million)

6.5.2 Market Size, By Product, 2016-2026 (USD Million)

6.5.3 Market Size, By Dosage Form, 2016-2026 (USD Million)

6.5.4 Brazil

6.5.4.1 Market Size, By Product, 2016-2026 (USD Million)

6.5.4.2 Market Size, By Dosage Form, 2016-2026 (USD Million)

6.5.5 Mexico

6.5.5.1 Market Size, By Product, 2016-2026 (USD Million)

6.5.5.2 Market Size, By Dosage Form, 2016-2026 (USD Million)

6.5.6 Argentina

6.5.6.1 Market Size, By Product, 2016-2026 (USD Million)

6.5.6.2 Market Size, By Dosage Form, 2016-2026 (USD Million)

6.6 MEA

6.6.1 Market Size, By Country 2016-2026 (USD Million)

6.6.2 Market Size, By Product, 2016-2026 (USD Million)

6.6.3 Market Size, By Dosage Form, 2016-2026 (USD Million)

6.6.4 Saudi Arabia

6.6.4.1 Market Size, By Product, 2016-2026 (USD Million)

6.6.4.2 Market Size, By Dosage Form, 2016-2026 (USD Million)

6.6.5 UAE

6.6.5.1 Market Size, By Product, 2016-2026 (USD Million)

6.6.5.2 Market Size, By Dosage Form, 2016-2026 (USD Million)

6.6.6 South Africa

6.6.6.1 Market Size, By Product, 2016-2026 (USD Million)

6.6.6.2 Market Size, By Dosage Form, 2016-2026 (USD Million)

Chapter 7 Company Landscape

7.1 Competitive Analysis, 2020

7.2 Ashland Global Holdings Inc.

7.2.1 Company Overview

7.2.2 Financial Analysis

7.2.3 Strategic Positioning

7.2.4 Info-Graphic Analysis

7.3 Roquette Frères S.A

7.3.1 Company Overview

7.3.2 Financial Analysis

7.3.3 Strategic Positioning

7.3.4 Info-Graphic Analysis

7.4 FMC Corporation

7.4.1 Company Overview

7.4.2 Financial Analysis

7.4.3 Strategic Positioning

7.4.4 Info-Graphic Analysis

7.5 DFE Pharma

7.5.1 Company Overview

7.5.2 Financial Analysis

7.5.3 Strategic Positioning

7.5.4 Info-Graphic Analysis

7.6 Huber Corporation

7.6.1 Company Overview

7.6.2 Financial Analysis

7.6.3 Strategic Positioning

7.6.4 Info-Graphic Analysis

7.7 Nippon Soda Co., Ltd.

7.7.1 Company Overview

7.7.2 Financial Analysis

7.7.3 Strategic Positioning

7.7.4 Info-Graphic Analysis

7.8 The Dow Chemical Company

7.8.1 Company Overview

7.8.2 Financial Analysis

7.8.3 Strategic Positioning

7.8.4 Info-Graphic Analysis

7.9 BASF SE

7.9.1 Company Overview

7.9.2 Financial Analysis

7.9.3 Strategic Positioning

7.9.4 Info-Graphic Analysis

7.10 Roquette Frères S.A.

7.10.1 Company Overview

7.10.2 Financial Analysis

7.10.3 Strategic Positioning

7.10.4 Info-Graphic Analysis

7.11 Merck KGaA

7.11.1 Company Overview

7.11.2 Financial Analysis

7.11.3 Strategic Positioning

7.11.4 Info-Graphic Analysis

7.12 Other Companies

7.12.1 Company Overview

7.12.2 Financial Analysis

7.12.3 Strategic Positioning

7.12.4 Info-Graphic Analysis

The Global Superdisintegrants Market has been studied from the year 2019 till 2026. However, the CAGR provided in the report is from the year 2021 to 2026. The research methodology involved three stages: Desk research, Primary research, and Analysis & Output from the entire research process.

The desk research involved a robust background study which meant referring to paid and unpaid databases to understand the market dynamics; mapping contracts from press releases; identifying the key players in the market, studying their product portfolio, competition level, annual reports/SEC filings & investor presentations; and learning the demand and supply-side analysis for the Superdisintegrants Market.

The primary research activity included telephonic conversations with more than 50 tier 1 industry consultants, distributors, and end-use product manufacturers.

Finally, based on the above thorough research process, an in-depth analysis was carried out considering the following aspects: market attractiveness, current & future market trends, market share analysis, SWOT analysis of the company and customer analytics.

We value your investment and offer free customization with every report to fulfil your exact research needs.

This website is secure and your personal details are safe. Privacy

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

What is the projected market size of the global superdisintegrants market?

The global superdisintegrants market size is projected to grow at a CAGR of 7.5% during the forecast period (2021-2026).

Who are the major vendors in the superdisintegrants market?

Key and innovative vendors in the superdisintegrants market include Ashland Global Holdings Inc., BASF SE, Merck KGaA, DuPont, Roquette Frères S.A., FMC Corporation, DFE Pharma, Huber Corporation, JRS Pharma, Avantor, Corel Pharma Chem, and Nippon Soda Co., Ltd.

Which region has the highest market share in the superdisintegrants market?

North America is estimated to hold the highest market share in the superdisintegrants market.

What is the Covid-19 impact on future superdisintegrants manufacturers?

Globally, the Covid-19 impact on the future superdisintegrants market will be quite significant for the manufacturers since demand has fluctuated owing to the lockdown in key nations throughout the world. North America would be leading because of the improved innovation in the development of superdisintegrants. Subsequently, Asia Pacific will be growing the fastest because of the increased outsourcing of active ingredients.

What are the major drivers in the superdisintegrants market?

The major driving factors for the superdisintegrants market include the expansion in the generic market, the emergence of new superdisintegrants for the pharmaceutical sector, rising geriatric population who have difficulty with swollen tablets or capsules, rising demands for Superdisintegrants products, growing R&D activities, increased R&D investment, and rising adoption rate of novel drug delivery systems.